Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001354488-16-007114
Filing Date
2016-04-27
Accepted
2016-04-27 16:00:57
Documents
5
Effectiveness Date
2016-04-27

Document Format Files

Seq Description Document Type Size
1 NOTICE AND ACCESS immy_defa14a.htm DEFA14A 37431
2 phone.jpg GRAPHIC 8848
3 internet.jpg GRAPHIC 8113
4 mail.jpg GRAPHIC 8542
5 fax.jpg GRAPHIC 8253
  Complete submission text file 0001354488-16-007114.txt   64012
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35814 | Film No.: 161595284
SIC: 2834 Pharmaceutical Preparations